Craif

About:

Craif is a biotechnology company that develops a cancer diagnosis algorithm using microRNA database and machine learning technology.

Website: https://craif.com/

Top Investors: Global Brain Corporation, ANRI, VentureOut, MedTech Innovator, MTG Ventures

Description:

Icaria's mission is to create a new society in which people will not lose their lives by using urine tests to provide "early, painless and accurate early diagnosis of cancer."It is known that detecting cancer early increases the survival rate 5 to 10 times and greatly improves the prognosis. However, it is not unusual for many cancers to have no subjective symptoms, and when they become aware they have progressed to a stage where treatment is impossible. The most effective way to detect cancer at an early stage that can be treated is to have regular and high-precision cancer diagnosis, but existing cancer diagnosis is painful and However, many of them are not accurate enough and are not suitable for regular diagnosis and early stage diagnosis.

Total Funding Amount:

$11.3M

Headquarters Location:

Tokyo, Tokyo, Japan

Founded Date:

2018-05-22

Founders:

Onose Ryuichi, Takeshita Daiki

Number of Employees:

11-50

Last Funding Date:

2024-05-29

IPO Status:

Private

© 2024 MyAiNote.com